2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Retinal Artery Occlusion: new trials by email Literature Review of Retinal Artery Occlusion trials Research Report on Retinal Artery Occlusion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TENecteplase in Central Retinal Artery Occlusion Stuy (TenCRAOS) Intravenous injection of Tenecteplase and one dose of placebo tablet, One tablet of Acetylsalicylic Acid and one dose of IV placebo - Central Retinal Artery Occlusion | Phase 3 | Completed | Oslo University Hospital | 81 | 2020-10-30 | 2025-09-29 |
| A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion Alteplase, acetylsalicylic acid, Placebo Oral Tablet - Central Retinal Artery Occlusion | Phase 3 | Completed | Nantes University Hospital | 70 | 2018-06-08 | 2024-01-24 |
Arterial Occlusive Diseases (2) · Cardiovascular Diseases (2) · Eye Diseases (2) · Retinal Diseases (2) · Vascular Diseases (2)
Aspirin (2) · Tenecteplase (1) · Tissue Plasminogen Activator (1)
Nantes University Hospital (1) · Oslo University Hospital (1)
Belgium (1) · Denmark (1) · Finland (1) · France (1) · Lithuania (1) · Norway (1) · Sweden (1)
PMID 39614619, PMID 41109232, PMID 41604638
2018 (1)